Clinical Trial Update: Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of dapagliflozin on insulin secretion and insulin sensitivity in adults with prediabetes or impaired fasting glucose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Fasting Glucose
• Impaired Glucose Tolerance
• Prediabetes

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Guadalajara | Conditions: Prediabetes, Impaired Fasting Glucose | Phase 4 | Status: COMPLETED | Results posted: 2020-10-08